SCHEMBL1386119

SCHEMBL1386119

O=C1C(=O)N(Cc2cc3cnccc3[nH]2)CCN1CC=Cc1ccc(Cl)s1

nearest known ligand 0.68

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.68
F2 P00734 2/20 0.49
PRMT5 O14744 2/20 0.40
WDR77 Q9BQA1 2/20 0.40
DAO P14920 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
HRH4 Q9H3N8 1/20 0.32
P2RX7 Q99572 1/20 0.32
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1386118 1.00 F10 (0.68) F10F2PRMT5WDR77DAO
SCHEMBL1384460 0.93 F10 (0.60) F10F2PRMT5WDR77DAO
SCHEMBL4394248 0.93 F10 (0.60) F10F2PRMT5WDR77DAO
SCHEMBL1653488 0.90 F10 (0.71) F10F2PRMT5WDR77
SCHEMBL4391729 0.90 F10 (0.71) F10F2PRMT5WDR77
SCHEMBL1386462 0.85 F10 (0.68) F10F2PRMT5WDR77DAO
SCHEMBL1386464 0.85 F10 (0.68) F10F2PRMT5WDR77DAO
SCHEMBL1385786 0.85 F10 (0.58) F10F2PRMT5WDR77HCRTR1
SCHEMBL1386999 0.83 F10 (0.56) F10F2PRMT5WDR77
SCHEMBL1386997 0.83 F10 (0.56) F10F2PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 US disclosed